Drug
Insulin glulisine clinical trials
Also written Apidra.
How studies write it
Studies that test it under each name
Brand
- Apidra
- 27
Development codes
Studies by the year they started
65 studies that test it; most in 2004 (10)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 10 |
| 2005 | 7 |
| 2006 | 3 |
| 2007 | 9 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 7 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 43 · Other 22
Sanofi (38) · Medical University of Warsaw (5) · Emory University (2) · HealthPartners Institute (2) · ikfe-CRO GmbH (2) · Geropharm (1) · Kinderkrankenhaus auf der Bult (1) · Spectrum Health Hospitals (1)
Often tested with
Tested in the same studies.
Insulin Glargine (25) · Insulin Aspart (10) · Insulin Lispro (8) · Insulin (4) · Repaglinide (1) · Acarbose (1) · Insulin degludec (1) · Metformin (1)
Studies
Open first, then newest update. How each study uses insulin glulisine is read from its arms, and is right about nine times in ten.
Testing it · 65
- The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.CompletedPhase 4Medical University of WarsawNCT04124302Written as Insulin Glulisine
- Evaluation of Insulin Glulisine (GP40321) Compared to Insulin Glulisine (Apidra® SoloStar®) in Type 1 Diabetes Mellitus PatientsCompletedPhase 3GeropharmNCT07070752Written as GP40321
- Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)CompletedPhase 4Kinderkrankenhaus auf der BultNCT02914886Written as Apidra
- Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 DiabetesTerminatedPhase 4Centre Hospitalier Universitaire DijonNCT02048189Written as APIDRA
- Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index MealCompletedPhase 4Medical University of WarsawNCT04019821Written as Insulin Glulisine
- The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal ChildrenCompletedPhase 4Spectrum Health HospitalsNCT00913497Written as insulin glulisine
- A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes MellitusCompletedPhase 1SanofiNCT02910518Written as Insulin glulisine (U300)
- Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin TherapyCompletedPhase 4SanofiNCT03359837Written as Insulin Glulisine
- Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study)CompletedPhase 4Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludNCT03328845Written as Apidra
- Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's DiseaseTerminatedPhase 2HealthPartners InstituteNCT02503501Written as Insulin glulisine
- Comparison on Efficacy and Safety of Three Inpatient Insulin Therapy in Type2 DMCompletedNot applicableCairo UniversityNCT01855243Written as glulisine
- Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) PatientsCompletedPhase 3Emory UniversityNCT01792830Written as Glulisine
- Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational DiabetesCompletedPhase 2Sansum Diabetes Research InstituteNCT01662921Written as Insulin glulisine
- Basal Bolus vs. Sliding Scale for Treatment of Diabetic Patients in Medical WardsCompletedPhase 4HaEmek Medical Center, IsraelNCT01594060Written as Insulin glulisine, Insulin glargine
- Normal Versus Dual Wave Insulin Bolus for High-protein FoodCompletedPhase 4Medical University of WarsawNCT02276859Written as insulin glulisine
- Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 DiabetesCompletedPhase 1Novo Nordisk A/SNCT00824668Written as insulin glulisine
- Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.Status unknownPhase 4Medical University of WarsawNCT02685449Written as Insulin glulisine
- Evaluation of the Prandial Treatment Adjustment Effect Via Continuous Glucose Monitoring on Type 2 Diabetes Mellitus (DM) Patients Uncontrolled With a Basal Insulin or Premix Once a DayCompletedPhase 4SanofiNCT01234597Written as INSULIN GLULISINE (HMR1964)
- Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and AdolescentsCompletedPhase 3SanofiNCT00115570Written as Insulin glulisine
- Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.CompletedPhase 2HealthPartners InstituteNCT01436045Written as Insulin glulisine
See all 65 studies that test insulin glulisine →
Given in every arm · 12 — insulin glulisine is usual care beside what is tested
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)CompletedPhase 3SanofiNCT03529123Written as Insulin Glulisine (HMR1964)
- Glargine U300 Hospital TrialCompletedPhase 4Emory UniversityNCT03013985Written as Glulisine Insulin
- Investigation of the Safety of Intranasal Glulisine in Down SyndromeCompletedPhase 1HealthPartners InstituteNCT02432716Written as Insulin glulisine
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes MellitusCompletedPhase 2Halozyme TherapeuticsNCT01194245Written as Insulin glulisine
- CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)CompletedPhase 4Halozyme TherapeuticsNCT01848990Written as Insulin glulisine
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes MellitusCompletedPhase 2Halozyme TherapeuticsNCT01194258Written as Insulin glulisine
- A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs AloneCompletedPhase 1Halozyme TherapeuticsNCT00979875Written as Insulin glulisine
- Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.CompletedPhase 4SanofiNCT01122979Written as INSULIN GLULISINE
- Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative StudyCompletedPhase 4SanofiNCT01121835Written as INSULIN GLULISINE
- Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral NutritionTerminatedPhase 4SanofiNCT01081938Written as INSULIN GLULISINE
- Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory ControlTerminatedPhase 4SanofiNCT00283049Written as Insulin Glulisine
- Opposing Step-by-step Insulin Reinforcement to Intensified StrategyCompletedPhase 3SanofiNCT00174642Written as Insulin Glulisine
As the comparator · 1 — what is tested is compared with insulin glulisine
Codes
What other systems call insulin glulisine · ClinicalTrials.gg INT004581
- MeSH (NLM) C479079insulin glulisineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7XIY785AZDINSULIN GLULISINEConfirmed FDA, NLM, Wikidata
- RxNorm 400008Confirmed FDA, Wikidata
- Wikidata Q6042242insulin glulisineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65921Insulin GlulisineConfirmed FDA, Wikidata
- DrugBank DB01309One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C479079 | insulin glulisine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7XIY785AZD | INSULIN GLULISINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 400008 | — | Confirmed FDA, Wikidata |
| Wikidata | Q6042242 | insulin glulisine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65921 | Insulin Glulisine | Confirmed FDA, Wikidata |
| DrugBank | DB01309 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.